TRxADE Health Inc expected to post a loss of 8  cents a share - Earnings Preview

Scienture Holdings

23/07/2022 03:02

* TRxADE Health Inc  MEDS.OQ   MEDS.O  is expected to show a
rise
in quarterly revenue when it reports  results on July 25. 
    * The Land O' Lakes Florida-based  company is expected to
report 
a 54.4% increase in revenue to $2.931 million from $1.9 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for TRxADE Health Inc
is for
a loss of 8 cents per share. For the same quarter last year, the
company reported a loss of 17 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for TRxADE
Health Inc
is $4​, above​ its last closing price of $1.67. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -0.11       -0.11      -0.12     Missed  -5.9
 Dec. 31 2022  -0.16       -0.15      -0.10     Beat    33.3
 Sep. 30 2021  -0.13       -0.13      -0.16     Missed  -23.1​
 Jun. 30 2021  -0.09       -0.09      -0.17     Missed  -96.1
 ​​Mar.        -0.05       -0.05      -0.08     Missed  -71.4
 31 2021                                                
 Dec. 31 2020  0.01        0.01       -0.20     Missed  -2,100
                                                        ​
 Sep. 30 2020  0.03        0.03       0.02      Missed  -33.3
 Jun. 30 2020  0.01        0.01       -0.07     Missed  -800
 This summary was machine generated July 23 at 02:01 GMT.  All
figures in US dollars  unless otherwise stated